Content area

Abstract

External control arms can inform early clinical development of experimental drugs and provide efficacy evidence for regulatory approval. However, accessing sufficient real-world or historical clinical trials data is challenging. Indeed, regulations protecting patients’ rights by strictly controlling data processing make pooling data from multiple sources in a central server often difficult. To address these limitations, we develop a method that leverages federated learning to enable inverse probability of treatment weighting for time-to-event outcomes on separate cohorts without needing to pool data. To showcase its potential, we apply it in different settings of increasing complexity, culminating with a real-world use-case in which our method is used to compare the treatment effect of two approved chemotherapy regimens using data from three separate cohorts of patients with metastatic pancreatic cancer. By sharing our code, we hope it will foster the creation of federated research networks and thus accelerate drug development.

External Control Arm methods for clinical trials were developed to compare the efficacy of a treatment to a control group that is built with data from external sources. Here, the authors present FedECA, a privacy-enhancing method for analyzing treatment effects across institutions, streamlining multi-centric trial design and thereby accelerating drug development while minimizing patient data exposure.

Details

1009240
Company / organization
Title
FedECA: federated external control arms for causal inference with time-to-event data in distributed settings
Author
Ogier du Terrail, Jean 1 ; Klopfenstein, Quentin 1 ; Li, Honghao 1 ; Mayer, Imke 1 ; Loiseau, Nicolas 1 ; Hallal, Mohammad 1 ; Debouver, Michael 1 ; Camalon, Thibault 1 ; Fouqueray, Thibault 1 ; Arellano Castro, Jorge 1 ; Yanes, Zahia 1 ; Dahan, Laëtitia 2 ; Taïeb, Julien 3 ; Laurent-Puig, Pierre 4 ; Bachet, Jean-Baptiste 5 ; Zhao, Shulin 6 ; Nicolle, Remy 7 ; Cros, Jérôme 8 ; Gonzalez, Daniel 9 ; Carreras-Torres, Robert 10 ; Garcia Velasco, Adelaida 11 ; Abdilleh, Kawther 12 ; Doss, Sudheer 12 ; Balazard, Félix 1 ; Andreux, Mathieu 1 

 Owkin, Inc., New York, NY, USA 
 Department of Digestive Oncology, Hôpital la Timone, Marseille, France (ROR: https://ror.org/05jrr4320) (GRID: grid.411266.6) (ISNI: 0000 0001 0404 1115) 
 GI oncology department Georges Pompidou European Hospital, Université Paris Cité, CARPEM CCC, 20 rue leblanc 75015 Paris, APHP, Paris, France (ROR: https://ror.org/05f82e368) (GRID: grid.508487.6) (ISNI: 0000 0004 7885 7602) 
 Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Paris, France (ROR: https://ror.org/00dmms154) (GRID: grid.417925.c); Institut du Cancer Paris CARPEM, AP-HP Centre, Hôpital Européen Georges Pompidou, Paris, France (ROR: https://ror.org/016vx5156) (GRID: grid.414093.b) (ISNI: 0000 0001 2183 5849) 
 Sorbonne University, Hepatogastroenterology and digestive oncology department, Pitié Salpêtrière hospital, APHP, Paris, France (ROR: https://ror.org/00pg5jh14) (GRID: grid.50550.35) (ISNI: 0000 0001 2175 4109) 
 Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Paris, France (ROR: https://ror.org/00dmms154) (GRID: grid.417925.c) 
 Université Paris Cité, Centre de Recherche sur l’Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-75018, Paris, France (ROR: https://ror.org/02feahw73) (GRID: grid.4444.0) (ISNI: 0000 0001 2112 9282) 
 Department of Pathology, Université Paris Cité - FHU MOSAIC, Beaujon Hospital, Clichy, France (ROR: https://ror.org/03jyzk483) (GRID: grid.411599.1) (ISNI: 0000 0000 8595 4540) 
 Fédération Francophone de Cancérologie Digestive, Dijon, France (ROR: https://ror.org/02q7qcb13) (GRID: grid.476348.a) 
10  Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Catalonia, Spain (ROR: https://ror.org/020yb3m85) (GRID: grid.429182.4) 
11  Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Catalonia, Spain (ROR: https://ror.org/020yb3m85) (GRID: grid.429182.4); Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona, Catalonia, Spain (ROR: https://ror.org/01j1eb875) (GRID: grid.418701.b) (ISNI: 0000 0001 2097 8389) 
12  Pancreatic Cancer Action Network, El Segundo, CA, USA (ROR: https://ror.org/03t5n9b81) (GRID: grid.429965.5) (ISNI: 0000 0004 5900 2692) 
Publication title
Volume
16
Issue
1
Pages
7496
Number of pages
23
Publication year
2025
Publication date
2025
Section
Article
Publisher
Nature Publishing Group
Place of publication
London
Country of publication
United States
Publication subject
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-08-13
Milestone dates
2025-07-24 (Registration); 2024-10-28 (Received); 2025-07-24 (Accepted)
Publication history
 
 
   First posting date
13 Aug 2025
ProQuest document ID
3239225046
Document URL
https://www.proquest.com/scholarly-journals/fedeca-federated-external-control-arms-causal/docview/3239225046/se-2?accountid=208611
Copyright
© The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-12-10
Database
ProQuest One Academic